Fuse Medical Q3 net loss shrinks 99% to $9.4k; revenue up 7% to $4.5M

Fuse Medical, Inc.

Net revenues $4.5M (+7% YoY); gross profit $3M (67% margin vs 56% in prior year).
Net loss improved to $9,376 from $697,036 loss; loss reduced ~99% YoY.
Adjusted EBITDA positive $131,241 vs loss of $630,549 in Q3 2021, a 121% improvement.
Launched Fuse PSS Pedicle Screw System with minimally invasive options in Q3.
Expects continued growth from new product launches and direct sales force expansion.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Fuse Medical, Inc. reported third quarter ended September 30, 2022 results: revenue $4.5 million, net income net loss was $9,376.

Period: third quarter ended September 30, 2022
Revenue: $4.5 million
Net income: net loss was $9,376
Result: reported results

Exact text from the filing

Net revenues for the quarter ended September 30, 2022 were $4.5 million, compared to $4.2 million for the quarter ended September 30, 2021 which was an increase of approximately 7%.

View on SEC.gov

Browse all earnings releases →

Fuse Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-22-038045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.